Literature DB >> 16547279

Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis.

Amilcar S Damazo1, Simon Yona, Roderick J Flower, Mauro Perretti, Sonia M Oliani.   

Abstract

The recent appreciation of the role played by endogenous counterregulatory mechanisms in controlling the outcome of the host inflammatory response requires specific analysis of their spatial and temporal profiles. In this study, we have focused on the glucocorticoid-regulated anti-inflammatory mediator annexin 1. Induction of peritonitis in wild-type mice rapidly (4 h) produced the expected signs of inflammation, including marked activation of resident cells (e.g., mast cells), migration of blood-borne leukocytes, mirrored by blood neutrophilia. These changes subsided after 48-96 h. In annexin 1(null) mice, the peritonitis response was exaggerated ( approximately 40% at 4 h), with increased granulocyte migration and cytokine production. In blood leukocytes, annexin 1 gene expression was activated at 4, but not 24, h postzymosan, whereas protein levels were increased at both time points. Locally, endothelial and mast cell annexin 1 gene expression was not detectable in basal conditions, whereas it was switched on during the inflammatory response. The significance of annexin 1 system plasticity in the anti-inflammatory properties of dexamethasone was assessed. Clear induction of annexin 1 gene in response to dexamethasone treatment was evident in the circulating and migrated leukocytes, and in connective tissue mast cells; this was associated with the steroid failure to inhibit leukocyte trafficking, cytokine synthesis, and mast cell degranulation in the annexin 1(null) mouse. In conclusion, understanding how inflammation is brought under control will help clarify the complex interplay between pro- and anti-inflammatory pathways operating during the host response to injury and infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547279      PMCID: PMC1868080          DOI: 10.4049/jimmunol.176.7.4410

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia?

Authors:  Karen Y Stokes; D Neil Granger
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

Review 2.  Transmigration through venular walls: a key regulator of leukocyte phenotype and function.

Authors:  Sussan Nourshargh; Federica M Marelli-Berg
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

3.  Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26).

Authors:  Paola Maderna; Simon Yona; Mauro Perretti; Catherine Godson
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

Review 4.  Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

Authors:  Stephen J Galli; Janet Kalesnikoff; Michele A Grimbaldeston; Adrian M Piliponsky; Cara M M Williams; Mindy Tsai
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

5.  Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro.

Authors:  Bristi E Chatterjee; Simon Yona; Guglielmo Rosignoli; Rebecca E Young; Sussan Nourshargh; Roderick J Flower; Mauro Perretti
Journal:  J Leukoc Biol       Date:  2005-07-06       Impact factor: 4.962

6.  Molecular circuits of resolution: formation and actions of resolvins and protectins.

Authors:  Gerard L Bannenberg; Nan Chiang; Amiram Ariel; Makoto Arita; Eric Tjonahen; Katherine H Gotlinger; Song Hong; Charles N Serhan
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

7.  Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation.

Authors:  Amilcar S Damazo; Simon Yona; Fulvio D'Acquisto; Roderick J Flower; Sonia M Oliani; Mauro Perretti
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

8.  A novel effect for annexin 1-derived peptide ac2-26: reduction of allergic inflammation in the rat.

Authors:  Christianne Bandeira-Melo; André Gustavo C Bonavita; Bruno L Diaz; Patricia M R E Silva; Vinícius F Carvalho; Peter J Jose; Roderick J Flower; Mauro Perretti; Marco A Martins
Journal:  J Pharmacol Exp Ther       Date:  2005-03-22       Impact factor: 4.030

9.  Dexamethasone up-regulates the inhibitory adaptor protein Dok-1 and suppresses downstream activation of the mitogen-activated protein kinase pathway in antigen-stimulated RBL-2H3 mast cells.

Authors:  Takaaki Hiragun; Ze Peng; Michael A Beaven
Journal:  Mol Pharmacol       Date:  2004-12-17       Impact factor: 4.436

10.  Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: role of intercellular adhesion molecule 1 and KC.

Authors:  A Tailor; A Tomlinson; A Salas; J Panés; D N Granger; R J Flower; M Perretti
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

View more
  55 in total

Review 1.  Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.

Authors:  Mauro Perretti; Jesmond Dalli
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

2.  Annexin A1 regulates intestinal mucosal injury, inflammation, and repair.

Authors:  Brian A Babbin; Mike G Laukoetter; Porfirio Nava; Stefan Koch; Winston Y Lee; Christopher T Capaldo; Eric Peatman; Eric A Severson; Roderick J Flower; Mauro Perretti; Charles A Parkos; Asma Nusrat
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.

Authors:  Vincenzo Brancaleone; Jesmond Dalli; Stefania Bena; Roderick J Flower; Giuseppe Cirino; Mauro Perretti
Journal:  J Immunol       Date:  2011-03-11       Impact factor: 5.422

Review 4.  Control of myeloid cell trafficking in resolution.

Authors:  Lucy V Norling; Mauro Perretti
Journal:  J Innate Immun       Date:  2013-04-30       Impact factor: 7.349

5.  Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner.

Authors:  Jenna L Cash; Annabel R Christian; David R Greaves
Journal:  J Immunol       Date:  2010-04-02       Impact factor: 5.422

6.  Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors.

Authors:  T Montero-Melendez; J Dalli; M Perretti
Journal:  Cell Death Differ       Date:  2012-12-07       Impact factor: 15.828

7.  Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair.

Authors:  Giovanna Leoni; Ashfaqul Alam; Philipp-Alexander Neumann; J David Lambeth; Guangjie Cheng; James McCoy; Roland S Hilgarth; Kousik Kundu; Niren Murthy; Dennis Kusters; Chris Reutelingsperger; Mauro Perretti; Charles A Parkos; Andrew S Neish; Asma Nusrat
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

8.  Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation.

Authors:  Thaís Santana Gastardelo; Amílcar Sabino Damazo; Jesmond Dalli; Roderick J Flower; Mauro Perretti; Sonia Maria Oliani
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

9.  Macrophage migration inhibitory factor counter-regulates dexamethasone-induced annexin 1 expression and influences the release of eicosanoids in murine macrophages.

Authors:  Yu Sun; Yu Wang; Jia-Hui Li; Shi-Hui Zhu; Hong-Tai Tang; Zhao-Fan Xia
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

10.  Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion.

Authors:  Giovanna Leoni; Hetal B Patel; André L F Sampaio; Felicity N E Gavins; Joanne F Murray; Paolo Grieco; Stephen J Getting; Mauro Perretti
Journal:  FASEB J       Date:  2008-08-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.